SCHEMBL19275928

SCHEMBL19275928

C/C=C/C(=O)Nc1cc(/C=C\c2cc(OC)c(OC)c(OC)c2)ccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 4/20 0.59
▸ BCHE P06276 1/20 0.56
▸ TUBB1 Q9H4B7 4/20 0.55
▸ TUBB4A P04350 3/20 0.55
▸ TUBB P07437 3/20 0.55
▸ TUBA3C P0DPH7 3/20 0.55
▸ TUBA1B P68363 3/20 0.55
▸ TUBA4A P68366 3/20 0.55
▸ TUBB4B P68371 3/20 0.55
▸ TUBB3 Q13509 3/20 0.55
▸ TUBB2A Q13885 3/20 0.55
▸ TUBB8 Q3ZCM7 3/20 0.55
▸ TUBA3E Q6PEY2 3/20 0.55
▸ TUBA1A Q71U36 3/20 0.55
▸ TUBA1C Q9BQE3 3/20 0.55
▸ TUBB6 Q9BUF5 3/20 0.55
▸ TUBB2B Q9BVA1 3/20 0.55
▸ HDAC3 O15379 1/20 0.55
▸ HDAC4 P56524 1/20 0.55
▸ HDAC1 Q13547 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20538477 0.93 KDM1A (0.68) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL20538479 0.93 KDM1A (0.68) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL20537858 0.91 KDM1A (0.72) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL20537857 0.91 KDM1A (0.72) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL19275931 0.91 BCHE (0.59) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL19275929 0.90 TUBB1 (0.60) BCHETUBB1TUBB4ATUBBTUBA3C
SCHEMBL20538508 0.89 MMP1 (0.67) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL20537840 0.89 KDM1A (0.64) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL20538510 0.89 MMP1 (0.67) KDM1ABCHETUBB1TUBB4ATUBB
SCHEMBL19800983 0.89 KDM1A (0.64) KDM1ABCHETUBB1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9878977-B2 N-((3,4,5-trimethoxystyryl)aryl)cinnamamide compounds as potential anticancer agents and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2018-01-30 — — US disclosed
US-20170240503-A1 N-((3,4,5-TRIMETHOXYSTYRYL)ARYL)CINNAMAMIDE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170240503-A1 N-((3,4,5-TRIMETHOXYSTYRYL)ARYL)CINNAMAMIDE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP51A1, CBR3 KDM1A 1609/4885BCHE 3267/4885TUBB1 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback